Skip to Main Content

Paper Details

Identification of intermediate risk breast cancer patients with 1-3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis.
Breast
3
2013
Author NameAffiliation
Barbro LinderholmSahlgrenska Academy and University Hospital, Karolinska Institutet
  • 1 - 1

Datasets

Release 1.2